JANUARY/FEBRUARY VOLUME 5, NUMBER 1

Page 1

THE PEER-REVIEWED FORUM FOR EVIDENCE IN BENEFIT DESIGN ™ JANUARY/FEBRUARY 2012

VOLUME 5, NUMBER 1

FOR PAYERS, PURCHASERS, POLICYMAKERS, AND OTHER HEALTHCARE STAKEHOLDERS

EDITORIAL

American Health & Drug Benefits: Reflections on the First 5 Years Gary M. Owens, MD

The Business Case for Ending Homelessness: Having a Home Improves Health, Reduces Healthcare Utilization and Costs Daniel G. Garrett, RPh, MS, FASHP

BUSINESS

Beyond the Cost of Biologics: Employer Survey Reveals Gap in Understanding Role of Specialty Pharmacy and Benefit Design F. Randy Vogenberg, RPh, PhD; Cheryl Larson, BA; Margaret Rehayem, MA; Larry Boress, MPA Stakeholder Perspective by Atheer A. Kaddis, PharmD REGULATORY

Primary Care Shortages: Strengthening This Sector Is Urgently Needed, Now and in Preparation for Healthcare Reform Sarah Collins, MBA Stakeholder Perspective by Gary M. Owens, MD CLINICAL

Daily Average Consumption of 2 Long-Acting Opioids: An Interrupted Time Series Analysis R. Amy Puenpatom, PhD; Sheryl L. Szeinbach, PhD, MS, BSPharm; Larry Ma, PhD; Rami H. Ben-Joseph, PhD; Kent H. Summers, PhD, BSPharm Stakeholder Perspective by Matthew Mitchell, PharmD, MBA

INDUSTRY TRENDS Employers, Health Plans, and New Drug Benefit Designs: A Shifting Landscape

©2012 Engage Healthcare Communications, LLC www.AHDBonline.com


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.